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Abstract
Background: Household (HH) contact tracing is a strategy that targets high risk groups for TB. Symptom based
screening is the standard used to identify HH contacts at risk for TB during HH contact tracing for TB. However, this
strategy may be limited due to poor performance in predicting TB. The objective of this study was to compare CXR
with Computer Aided Diagnosis (CAD) against symptom screen for defining presumptive TB and how TB detection
changes with each method.
Methods: Household contacts of consecutive index bacteriologically confirmed TB cases were visited by study
teams and given TB/HIV education to raise awareness of the risk of TB following close contact with a TB patient.
Contacts were encouraged to visit the health facility for screening; where symptoms history was obtained and opt
out HIV testing was provided as part of the screening process. CXR was offered to all regardless of symptoms,
followed by definitive sputum test with either Xpert MTB RIF or smear microscopy.
Results: Among 919 HH contacts that presented for screening, 865 were screened with CXR and 464 (53.6%) had
an abnormal CXR and the rest had a normal CXR. Among 444 HH contacts with valid sputum results, 274 (61.7%)
were symptom screen positive and 255 (57.4%) had an abnormal CXR. Overall, TB was diagnosed in 32/444 (7.2%);
13 bacteriologically unconfirmed and 19 bacteriologically confirmed. Of 19 bacteriologically confirmed TB 8 (42.1%)
were symptom screen negative contacts with an abnormal CXR and these 6/8 (75.0%) were HIV positive. Among
the 13 bacteriologically unconfirmed TB cases, 7 (53.8%) were HIV positive and all had an abnormal CXR.
Conclusion: Symptom screen if used alone with follow on definitive TB testing only for symptom screen positive
individuals would have missed eight of the 19 confirmed TB cases detected in this study. There is need to consider
use of other screening strategies apart from symptom screen alone for optimal rule out of TB especially in HIV
positive individuals that are at greatest risk of TB and present atypically.
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Background
Household (HH) contacts of newly diagnosed tuberculosis
(TB) patients are considered to be a high risk group for TB
[1–3]. In view of this, household contact tracing is recom-
mended as one of the strategies for TB control. The World
Health Organisation (WHO) recommends that HH con-
tacts that have symptoms suggestive of presumptive TB,
People Living with HIV (PLHIV) and children under 5 years
old must undergo clinical evaluation for TB [4]. Typically,
among HIV positive individuals, a person is considered to
be a presumptive TB patient if they have any one of the
symptoms; cough, fever, night sweats or weight loss [5, 6].
Among HIV negative patients, a person is generally consid-
ered to be a presumptive TB patient if they have a cough
greater or equal 2 weeks duration with or without other
symptoms of TB. Symptom screen to define presumptive
TB has been observed to result in missed active TB cases
among those who are symptom screen negative and are not
considered for follow on testing with definitive TB tests [7–9].
In 2016, the WHO recommendations for TB screening
included Chest X-ray (CXR) as a screening tool that is
more sensitive than symptom screen [10]. This is in rec-
ognition of the potential role of CXR in TB diagnosis es-
pecially with newer digital chest x-ray technology and
advances to electronically read CXRs making it possible
for CXR to be readily available in resource constrained
settings with high burden of TB and HIV and scarce
personnel to interpret CXRs [11–14]. New advances in
TB diagnostics such as Xpert MTB/RIF may also require
adjunct pre-screening tests that are highly sensitive and
have high negative predictive value, that reduce the
number needed to screen to detect one case of TB, ul-
timately reducing the cost of TB diagnosis [15–17].
HH contact tracing for contacts of patients with bac-
teriologically proven TB was conducted as part of an im-
plementation evaluation study of Xpert MTB/RIF, used
in conjunction with digital CXR with Computer Aided
Diagnosis (CAD) [18, 19]. In this study, we evaluated
using CAD as a tool to define presumptive TB as opposed
to the traditional method that uses symptom screening
among HH contacts of newly diagnosed TB patients with
bacteriologically confirmed TB.
Ethical considerations
The study had ethical approval from the University of
Zambia Biomedical Research Ethics Committee. Permission
to visit the household was initially obtained from the TB
patient and written informed consent was obtained from
the head of the household.
Methods
Study population and study setting
The study population comprised all household contacts
of patients diagnosed with bacteriologically confirmed
TB. This study was conducted in one government health
facility in Lusaka, Zambia.
Procedures
Newly diagnosed TB patients were informed about the
importance of screening household (HH) members for TB.
In the household, an enumeration form was completed and
this form collected data on the total number of HH mem-
bers disaggregated by age and sex, the total number of
rooms in the house and the total number of rooms used
for sleeping in.
TB and HIV information/education was given to those
present at the time of the visit, aimed at raising aware-
ness of the risk of TB following close contact exposure,
the increased risk for HIV positive individuals to develop
TB following exposure and why it was important to be
screened for both HIV and TB. All screening for TB and
HIV were done from the health facility and HH mem-
bers were invited to visit the health facility for screening.
At the health facility, all presenting HH contacts were
registered in the presumptive TB register and allocated a
unique identification number. The index identification
number was also recorded for purposes of linking the
HH contact to the index patient. All HH contacts were
offered HIV counselling and opt out HIV testing if they
did not know their HIV status. CXR was also offered to
all HH members and further testing of sputum with
Xpert was offered to those with an abnormal CXR whilst
those with a normal CXR were offered smear microscopy
according to the algorithm being evaluated (Fig. 1). The
full description of the algorithms being tested has been
given elsewhere [18, 19].
Briefly, using CAD (CAD4TB, version 1.08, Diagnostic
Image Analysis Group, Nijmegen, the Netherlands) [14, 20]
to electronically read CXRs, with set thresholds defining
normal CXR (CAD less than 61) and abnormal CXR (CAD
score greater than or equal to 61), HH members with an
abnormal CXR who were able to give sputum were tested
with Xpert, whilst those with normal CXR were tested
using smear microscopy according to the algorithm that
was being tested. Procedures for Xpert testing and smear
microscopy have been described elsewhere and followed
standard operating procedures [18, 19].
HH members with newly diagnosed HIV infection
were referred for HIV care under the routine services.
Children not diagnosed with TB were referred for IPT
under routine services according to the existing national
guidelines at the time. And all patients with TB detected
were referred to start TB treatment. Patients with no
TB detected had clinical evaluation and appropriate
management given as determined by the attending clin-
ician. Those commenced on TB treatment based on cli-
nician’s judgement were defined as having a clinical TB
diagnosis.
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Data collection
The data presented in this study was collected between
May 2013 and March 2014. Data collected on paper
based HH enumeration forms was double entered in an
access data base. Using the index barcode as the unique
identifier, HH enumeration data was merged with pre-
sumptive TB register data and TB treatment register.
For presumptive TB registration, an electronic register
was used which was based on routine presumptive TB
registers in use. The database was designed and devel-
oped using Microsoft Structured Query Language (SQL)
Server 2005 as the backend and Microsoft Office Visual
Basic.Net as the front end (Microsoft Corporation). Valid-
ation checks were also created to ensure that data were
entered correctly. To ensure the correctness of data, data
entry standards were developed on how to correctly cap-
ture data and how to handle missing data.
Data analysis
Data analysis was conducted using STATA (Stata Cor-
poration Version 13. College Station, TX, USA). Initial
descriptive analysis was conducted to show the number
of index TB cases accepting to have HH contact tracing
as well as to show the total number of household mem-
bers that were enumerated disaggregated by age (Fig. 1.)
Further descriptive analysis was conducted to show the
median HH size, and median number per sleeping room
(Table 1). Baseline characteristics of HH contacts that pre-
sented for screening are shown in Table 2. To understand
the impact of CAD on TB detection in relation to symp-
tom screening, analysis was conducted disaggregated by
HIV status to take care of the different definitions of
positive symptom screen (presumptive TB) among HIV
positive and HIV negative individuals (Figs. 3 and 4).
Contacts with unknown HIV status were grouped with
HIV positive individuals. Among HIV positive/unknown
status HH contacts, they were considered to have a posi-
tive symptom screen if they had any of cough, fever, night
sweats or weight loss. Among HIV negative contacts,
symptom disaggregation was; no cough present, cough
less than 2 weeks and cough for 2 weeks or more with or
without other symptoms.
Results
Of 1067 bacteriologically confirmed index TB cases,
consent to do contact tracing was obtained from 977
(91.6%), and 4297 individuals were enumerated from
HH that were visited. Of the 4297 enumerated HH con-
tacts, the majority of the household members were
15 years old and older; 2655 (61.8%) and children under
5 years were the least: 714 (16.6%) (Table 1.) The median
number of people per household was 4 (IQR 3–6), the
Fig. 1 Diagnostic Algorithm
Table 1 Household characteristics (Total number enumerated in
HH visited 4297)
Total Enumerated 4297(%)
Distribution by age
Total adults > = 15 years 2655 (61.8%)
Total 5–14 years 928 (21.6%)
Total < 5 years 714 (16.6%)
Median number of people/HH (IQR) 4 (3–6)
Median number rooms/HH (IQR) 2 (2–3)
Median number of sleeping rooms (IQR) 2 (1–2)
Median number of people/sleeping room (IQR) 2 (2–3)
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median number of rooms/ HH was 2 (IQR 2–3) and the
median number of people per sleeping room/ HH was 2
(IQR 2–3).
Only 919 (21.4%) out of 4297 enumerated HH con-
tacts presented to the health facility for screening during
the study period (Table 2). The median age of HH con-
tacts that presented was 15 (IQR 6–31), 549 (59.7%)
were female and 663 (72.1%) did not have a current
cough on presentation. HIV status was negative in 459
(49.9%), positive in 138 (15.0%) and unknown in 322
(35.0%). (Table 2).
Of the 919 HH contacts that presented, 865 (94.1%) had
a CXR done (Fig. 2). The CAD read 464/865 (53.6%)
CXRs as abnormal. Of those with abnormal CXR, 255
submitted a sputum sample for evaluation and 19 patients
had bacteriologically confirmed TB. Overall 444/919
(48.3%) of household contacts produced a sputum sample,
including 444/865 (51%) of those who had a CXR. Among
the 54 without a CXR, none produced a sputum sample.
Characteristics of those that did not produce sputum are
presented in Additional file 1: Table S1.
The total number of bacteriologically confirmed TB
cases detected was 19 (4.3%) out of 444 who had a spu-
tum sample evaluated representing 2.1% of all 919 who
presented for screening. Overall, considering both bac-
teriologically confirmed and clinically diagnosed TB, 32
(7.2%) out 444 with evaluable sputum were diagnosed
with TB, representing 3.5% of all 919 HH contacts that
presented for TB screening.
Among 460 HIV positive/ status unknown, 411 had
CXR done and 213 (51.8%) had a CXR read as abnormal.
Of these with abnormal CXR, 125 (58.7%) had no symp-
toms of TB whilst 88 (41.3%) reported any symptom of
TB (Fig. 3). Among 53 patients with no symptoms but
Table 2 Baseline characteristics of Household contacts
presenting to the health facility
Characteristic N = 919 (%)
Median age (IQR) 15 (6–31)
Female Sex 549 (59.7)
Cough and duration
No cough 663 (72.1)
< 2 weeks 172 (18.7)
2–8 weeks 67 (7.3)
>8 weeks 9 (1.0%)
Unknown duration 8
Previous TB 57 (6.2)
HIV status
Tested negative 260 (28.3)
Tested positive 35 (3.8)
Self-report -Negative 199 (21.6)
Self report-Positive 103 (11.2)
Unknown status 322 (35.3)
CXR result
Abnormal 464 (50.5)
Normal 401 (43.6)
Not done 54 (5.9)
Sputum results
Sputum negative for TB 425 (46.2)
Sputum positive for TB 19 (2.1)
No sputum evaluated 475 (51.7)
Fig. 2 Diagnostic cascade of HH contacts
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Fig. 3 Diagnostic flow of HIV Positive/Unknown status HH contacts
Fig. 4 Diagnostic cascade of HIV negative HH contacts
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with an abnormal CXR who submitted a sputum sample,
TB was detected in six patients (11.3%). Among those
with any symptom, who submitted a sputum sample, TB
was detected in 6 (12.5%) out of 48 patients.
Among 459 HIV negative HH contacts, 454 under-
went CXR screening, 251 (55.3%) had CXR scored as ab-
normal and among those with abnormal CXR, 182
(72.5%) reported no cough, 44 (17.5%) reported a cough
less than 2 weeks and 23 (9.2%) reported a cough of dur-
ation 2 weeks or more with or without other symptoms
of TB (Fig. 4). Two HH contacts had unknown cough
duration. Of those without a cough submitting sputum,
2 (2.0%) out 100 had TB detected. TB was detected in 2
(6.3%) out of 32 with cough less than 2 weeks and in 3
(15%) out of 20 with cough of 2 weeks or more. No TB
was detected among those with a normal CXR.
Among HIV positive/ unknown status group; TB was
clinically diagnosed in 6 (14.9%) out of 42 with any
symptom. There was one clinical diagnosis of TB among
those with any symptom but with a normal CXR. Among
HIV negative HH contacts, TB was clinically diagnosed
in 6 (4.1%) out of 145 HH contacts in whom sputum
examination was negative but had an abnormal CXR.
Details of clinical diagnosis in Additional file 2.
Discussion
The traditional definition of presumptive TB that uses
symptoms misses cases of TB [7, 8]. In this study, using
digital CXR with CAD to define presumptive TB found
active TB among symptom screen negative CXR abnormal
HH contacts accounting for 42% (8 out of 19) of all bac-
teriologically confirmed TB cases detected. This finding
suggests that CXR may have an important role in detec-
tion of TB especially among household contacts that may
present early without typical symptoms of TB and active
TB may be missed if dependent on symptom presentation
[7–9]. Larger studies are required to ascertain the benefit
of CXR screening in settings with high prevalence of TB
and HIV where early detection and treatment are one of
the TB control strategies.
Relying on symptom screen alone to define presump-
tive TB among PLHIV may be contributing to delayed
diagnosis of TB, poor outcomes of HIV treatment and
delayed IPT in patients that are wrongly designated as
presumptive TB due to the low negative predictive value
of symptom screen for TB [8, 21, 22]. The current WHO
guidelines for IPT in resource constrained high TB and
HIV burden settings recommend symptom screen to de-
termine eligibility for IPT [5]. The Zambian guidelines for
the management of TB in HIV infected persons recognises
this limitation and recommends that all HIV positive indi-
viduals enrolling in care should be screened for TB using
Xpert MTB RIF regardless of symptoms [23]. The sustain-
ability of this strategy is questionable in view of the high
number needed to screen to detect each case of TB and
the high consumable costs of Xpert. Using pre-screening
tools such as CXR can reduce the number needed to test
for each case of TB that is detected and has the potential
to reduce the cost of TB diagnosis [15, 16]. Careful costing
studies are required to determine the costs and cost-
effectiveness of using CXR as a pre-screening tool taking
into consideration initial capital investments for CXR in-
struments and recurrent costs.
Availability of CXR in this study also meant that CXR
was on hand for clinical evaluation of all those with a
negative sputum result. It has already been demonstrated
that availability of CXR at this primary care facility re-
sulted in empirical treatment being started on the same
day of presentation to the facility [19, 24], a significant
finding given that diagnosis in sputum negative patients
can take several weeks as patients are worked through the
diagnostic algorithm for bacteriologically unconfirmed
presumptive TB patients [25, 26]. Often CXR is not avail-
able at primary care facilities due the scarcity of qualified
staff to operate and interpret CXRs. Digital CXR with
CAD bypasses this barrier.
A low proportion of HH contacts presented for
screening at the health facility. HH contact tracing plays
a dual role; finding cases of TB as well as raising aware-
ness of the risk of TB following close contact with a TB
case. In this study, combined with HH contact tracing,
HH members were given education on the relationship
between TB and HIV, and encouraged to present to the
facility for screening. The number of contacts that pre-
sented for screening could only be ascertained during
the study period, once the study ended, it is not known
how many may have accessed the health service as a re-
sult of the contact with HH contact tracing teams.
The limitation of this study is that a low proportion of
enumerated HH contacts presented for screening. It
might be that those that presented could be the ones
with high risk for TB and may explain the observed high
prevalence of TB in this population. Though this study
does not provide accuracy of CXR compared to symp-
tom screening, the findings in this study indicate and re-
emphasise the need for systematic screening of high risk
populations such as close contacts of TB patients for
early detection of TB and provision of IPT.
Conclusion
Despite the noted limitation of small sample size, this
study adds evidence to the limitation of relying on symp-
tom screen alone to identify presumptive TB patients for
further testing with definitive TB tests. Symptom screen
alone would have missed eight out 19 (42%) confirmed
TB cases that were detected among HH contacts who
had no symptoms of TB but had an abnormal CXR ac-
cording to CAD. Symptom screen potentially misses
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early TB and might be contributing to the observed poor
outcomes of HIV patients due to missed TB. There is
need to consider use of other screening strategies such
as CXR with CAD which has been observed to have a
high sensitivity and high negative predictive value for TB
to identify those at highest risk for TB who should be
tested with follow on definitive TB testing. Larger evalu-
ation studies of CAD are required that should include
cost-effectiveness.
Additional files
Additional file 1: Comparison of HH contacts that submitted sputum and
those not submitting sputum. Contains comparison data of HH contacts that
submitted sputum and those that did not submit sputum. (DOCX 18 kb)
Additional file 2: Clinically diagnosed patients with abnormal chest-
xray. This file contains details of patients that were clinical diagnosed with
TB based on CXR abnormality. It has time to TB diagnosis, comments on
CXR abnormality that was observed, symptom screen and TB treatment
outcome where available. (XLSX 31 kb)
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